J P Buyniski

The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic.

Anthony W. Pircio, Jonas A. Gylys, R L Cavanagh et al. · PubMed · 1976 · 144 citations

Molecular Pharmacology, Synthetic Morphinan, Health Sciences +13

Behavioral suppressant effects of clonidine in strains of normotensive and hypertensive rats

Hugh A. Tilson, J. Chamberlain, Jonas A. Gylys et al. · European Journal of Pharmacology · 1977 · 54 citations

Hypertension, Medicine, Physiology +5

A potent new inhibitor of platelet aggregation and experimental thrombosis, anagrelide (BL-4162A)

John Fleming, J P Buyniski · Thrombosis Research · 1979 · 51 citations

Thrombopoiesis, Thrombosis, Potent New Inhibitor +13

Effect of butorphanol and morphine on pulmonary mechanics, arterial blood pressure and venous plasma histamine in the anesthetized dog.

John E. Schurig, R L Cavanagh, J P Buyniski · PubMed · 1978 · 45 citations

Pharmacotherapy, Dynamic Compliance, Anesthetic Administration +18

BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist properties.

Jonas A. Gylys, Rachael Wright, W D Nicolosi et al. · Journal of Pharmacology and Experimental Therapeutics · 1988 · 42 citations